MedMen Enterprises (MedMen Enterprises) EV-to-EBIT : -2.71 (As of Jun. 20, 2024)

View and export this data going back to 2018. Start your Free Trial

What is MedMen Enterprises EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, MedMen Enterprises's Enterprise Value is $371.7 Mil. MedMen Enterprises's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 was $-137.3 Mil. Therefore, MedMen Enterprises's EV-to-EBIT for today is -2.71.

The historical rank and industry rank for MedMen Enterprises's EV-to-EBIT or its related term are showing as below:

MMNFQ' s EV-to-EBIT Range Over the Past 10 Years
Min: -2.71 Med: 0 Max: 0
Current: -2.71

MMNFQ's EV-to-EBIT is not ranked
in the Drug Manufacturers industry.
Industry Median: 17.03 vs MMNFQ: -2.71

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. MedMen Enterprises's Enterprise Value for the quarter that ended in Mar. 2023 was $-85.5 Mil. MedMen Enterprises's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 was $-137.3 Mil. MedMen Enterprises's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2023 was 160.53%.

MedMen Enterprises EV-to-EBIT Historical Data

The historical data trend for MedMen Enterprises's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMen Enterprises EV-to-EBIT Chart

MedMen Enterprises Annual Data

Trend

Oct13

Oct14

Oct15

Oct16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

EV-to-EBIT

Get a 7-Day Free Trial

-2,431.07

-2.67

-0.57

-2.16

0.05

MedMen Enterprises Quarterly Data
	Apr18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
EV-to-EBIT	Get a 7-Day Free Trial															-2.35	0.05	0.62	0.87	0.67

Competitive Comparison of MedMen Enterprises's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedMen Enterprises's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's EV-to-EBIT falls into.

MedMen Enterprises EV-to-EBIT Calculation

MedMen Enterprises's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	371.696	/	-137.258
	=	-2.71

MedMen Enterprises's current Enterprise Value is $371.7 Mil.
MedMen Enterprises's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-137.3 Mil.

MedMen Enterprises (OTCPK:MMNFQ) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

MedMen Enterprises's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2023 )	=	EBIT	/	Enterprise Value (Q: Mar. 2023 )
	=	-137.258	/	-85.50252
	=	160.53 %

MedMen Enterprises's Enterprise Value for the quarter that ended in Mar. 2023 was $-85.5 Mil.
MedMen Enterprises's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-137.3 Mil.

MedMen Enterprises EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of MedMen Enterprises's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

MedMen Enterprises (MedMen Enterprises) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (OTCPK:MMNFQ) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

10115 Jefferson Boulevard, Culver City, CA, USA, 90232

Website

https://www.medmen.com

MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.